| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |